You are here: Welcome » Stephanie Carlin

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
stephanie_carlin [2022/05/01 20:45]
liam [Hamilton Health Sciences]
stephanie_carlin [2022/05/01 20:55] (current)
liam [Funding]
Line 26: Line 26:
  
 Her research interests include optimization of antithrombotic use in clinical practice. Her research interests include optimization of antithrombotic use in clinical practice.
 +
 +==== Funding ====
 +
 +Carlin received funding from [[pharmaceutical_companies:Sanofi]] for her advanced
 +practice thrombosis residency program.((Carlin, S. (2021, February 10). //Declaration of Interest.// Ontario COVID-19 Science Advisory Table. https://web.archive.org/web/20220501184628/https://covid19-sciencetable.ca/wp-content/uploads/2021/02/Declaration-of-Interest_Drugs-and-Biologics-Clinical-Practice-Guidelines-Working-Group_Stephanie-Carlin-1.pdf))
 +
 +She also received joint payment from [[pharmaceutical_companies:Bristol-Myers Squibb]] and [[pharmaceutical_companies:Pfizer]] for an "educational presentation to health professionals on atrial fibrillation.((Carlin, S., & Eikelboom, J. (2022). //Advances in anticoagulation: patients with bioprosthetic heart valves.// Cardiovascular Research, 118(3), e26–e28. https://doi.org/10.1093/cvr/cvab360))
Back to top